PF 07314470
Alternative Names: PF-07314470Latest Information Update: 31 Mar 2025
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 12 Feb 2025 Preclinical trials in Unspecified in USA (SC)
- 11 Feb 2025 Pfizer plans a phase I pharmacokinetic trial (In volunteers) in February 2025 (SC, Injection) (NCT06821750)